Search

Ricky Go

Examiner (ID: 10363)

Most Active Art Unit
2862
Art Unit(s)
2862, 2857
Total Applications
1038
Issued Applications
794
Pending Applications
80
Abandoned Applications
193
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
18/135477 Compositions And Methods For Reducing Major Adverse Cardiovascular Events Apr 16, 2023 Pending
18/135473 Compositions And Methods For Weight Loss In At Risk Patient Populations Apr 16, 2023 Pending
18/135475 Compositions And Methods For Weight Loss In At Risk Patient Populations Apr 16, 2023 Pending
18/134886 NANOSCALE PROCESS TO GENERATE REAGENTS SELECTIVE FOR INDIVIDUAL PROTEIN VARIANTS Apr 13, 2023 Pending
18/131746 TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS Apr 5, 2023 Pending
18/130112 ACTIVATABLE IL2 COMPOSITION AND METHODS OF USE Apr 2, 2023 Pending
18/189147 MOLECULAR RHEOSTAT FOR COFACTOR BALANCE Mar 22, 2023 Pending
18/176201 METHODS OF MODIFYING ANTIBODIES FOR PURIFICATION OF BISPECIFIC ANTIBODIES Feb 27, 2023 Pending
18/102392 Method for the Detection of Cancer Jan 26, 2023 Abandoned
18/102588 AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY Jan 26, 2023 Pending
18/099880 Method for the Detection of Cancer Jan 19, 2023 Abandoned
18/072306 BARLEY WITH VERY LOW LEVELS OF HORDEINS Nov 29, 2022 Pending
90/019130 NOVEL HERBICIDE RESISTANCE GENES Nov 17, 2022 Pending
17/984985 ANTI-SIALYL TN CHIMERIC ANTIGEN RECEPTORS Nov 9, 2022 Pending
17/981360 MODULATION OF SPLENOCYTES IN CELL THERAPY Nov 3, 2022 Abandoned
17/978982 MODULATION OF SPLENOCYTES IN CELL THERAPY Nov 1, 2022 Pending
17/938019 TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA Oct 3, 2022 Pending
Array ( [id] => 20478779 [patent_doc_number] => RE050753 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-01-20 [patent_title] => Recombinant adenoviruses and use thereof [patent_app_type] => reissue [patent_app_number] => 17/934479 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 25 [patent_no_of_words] => 11967 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/934479 		Recombinant adenoviruses and use thereof Sep 21, 2022 Issued
17/822623 MOLECULAR RHEOSTAT FOR COFACTOR BALANCE Aug 25, 2022 Pending
17/816698 Anti-Human OX40L Antibodies and Methods of Treatment Jul 31, 2022 Pending
Menu